Mary-Lou Smulders built a career in engineering, startups, and drone security, helping shape policy and technology while promoting mission-driven leadership, innovation, and safer airspace in an evolving global landscape.
by Shruthi Kamalanathan
BioHive Live 2026 brought Utah's life sciences community together at the Loveland Living Planet Aquarium, where speakers John Harris and Tracy Milgram delivered powerful stories connecting technology, genetics, and human impact.
by Mark Tullis
Level Education Group (South Jordan, UT) partners with CCBHC Workforce Accelerator to expand the behavioral health workforce, offering funded licensure support, training, and career pathways to address clinician shortages across three U.S. states.
by Mark Tullis
Level Education Group (South Jordan, UT) partners with CCBHC Workforce Accelerator to expand the behavioral health workforce, offering funded licensure support, training, and career pathways to address clinician shortages across three U.S. states.
by Mark Tullis
A Utah Valley University professor leads an international team developing Hip1-targeting compounds that could disarm tuberculosis bacteria rather than kill them outright, potentially enabling lower doses, fewer side effects, and simpler diagnostics.
by Mark Tullis
Mary-Lou Smulders built a career in engineering, startups, and drone security, helping shape policy and technology while promoting mission-driven leadership, innovation, and safer airspace in an evolving global landscape.
by Shruthi Kamalanathan
Nucleus Fund invests in Provo's Terraphene, a hemp-based materials startup with a nine-figure pallet supply deal, fire- and strength-tested building materials, and a pitch to help refill the Great Salt Lake by replacing thirsty alfalfa acreage with hemp.
DHS named Fortem Technologies (Lindon, UT) the only small business among seven prime contractors on a five-year, $1B+ counter-drone IDIQ. CEO Jon Gruen discusses the win, subcontractors Lockheed Martin and Microsoft, and plans to scale Utah manufacturing.
South Jordan-based Obra emerges from stealth with two linked products, Obra Jobs and Obra Hire, betting that AI broke hiring's inbound signal and that a trust-first, outbound-focused platform can restore it.
Mary-Lou Smulders built a career in engineering, startups, and drone security, helping shape policy and technology while promoting mission-driven leadership, innovation, and safer airspace in an evolving global landscape.
by Shruthi Kamalanathan
At BioHive Week's U Startup Launchpad, outgoing Recursion CEO Chris Gibson delivered an emotional meditation on people-first culture, while founders Warren Pettine and Carmen Kivisilid offered a ground-level tutorial on building lean, AI-native companies in real time.
by Mark Tullis
At BioHive Week's U Startup Launchpad, outgoing Recursion CEO Chris Gibson delivered an emotional meditation on people-first culture, while founders Warren Pettine and Carmen Kivisilid offered a ground-level tutorial on building lean, AI-native companies in real time.
by Mark Tullis
BioHive Live 2026 brought Utah's life sciences community together at the Loveland Living Planet Aquarium, where speakers John Harris and Tracy Milgram delivered powerful stories connecting technology, genetics, and human impact.
by Mark Tullis
BioHive Live 2026 brought Utah's life sciences community together at the Loveland Living Planet Aquarium, where speakers John Harris and Tracy Milgram delivered powerful stories connecting technology, genetics, and human impact.
by Mark Tullis
Level Education Group (South Jordan, UT) partners with CCBHC Workforce Accelerator to expand the behavioral health workforce, offering funded licensure support, training, and career pathways to address clinician shortages across three U.S. states.
by Mark Tullis
Level Education Group (South Jordan, UT) partners with CCBHC Workforce Accelerator to expand the behavioral health workforce, offering funded licensure support, training, and career pathways to address clinician shortages across three U.S. states.
by Mark Tullis
A Utah Valley University professor leads an international team developing Hip1-targeting compounds that could disarm tuberculosis bacteria rather than kill them outright, potentially enabling lower doses, fewer side effects, and simpler diagnostics.
by Mark Tullis